Back to Journals » OncoTargets and Therapy » Volume 12
Original Research
miR-596 suppresses the expression of Survivin and enhances the sensitivity of osteosarcoma cells to the molecular targeting agent anlotinib
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
4,768 | Dovepress* | 4,316+ | 825 | 5,141 | |
PubMed Central* | 452 | 147 | 599 | ||
Totals | 4,768 | 972 | 5,740 | ||
*Since 21 August 2019 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 1 | 0 | 0 | 0 | 1 |
View citations on PubMed Central and Google Scholar